Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Skyepharma, an Expert and Innovative CDMO Partner for tailor-made solutions in complex oral solids and bioproduction.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Sepiapterin

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Orsini Chosen as PTC Therapeutics' Sephience Pharmacy Partner
    Orsini Chosen as PTC Therapeutics' Sephience Pharmacy Partner

    30 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orsini-selected-as-specialty-pharmacy-partner-for-ptc-therapeutics-sephience-sepiapterin-302516729.html

    PR NEWSWIRE
    30 Jul 2025
    Share Share
    US FDA approves PTC Therapeutics' Metabolic Disorder Drug
    US FDA approves PTC Therapeutics' Metabolic Disorder Drug

    29 Jul 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-ptc-therapeutics-metabolic-disorder-drug-2025-07-28/

    REUTERS
    29 Jul 2025
    Share Share
    Sephience Gets EU OK for PKU Drug Sepiapterin
    Sephience Gets EU OK for PKU Drug Sepiapterin

    24 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sephience-sepiapterin-granted-marketing-authorization-by-the-european-commission-for-the-treatment-of-children-and-adults-living-with-phenylketonuria-pku-302490040.html

    PR NEWSWIRE
    24 Jun 2025
    Share Share
    Sephience (Sepiapterin) Approved by European Commission for PKU
    Sephience (Sepiapterin) Approved by European Commission for PKU

    23 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sephience-sepiapterin-granted-marketing-authorization-by-the-european-commission-for-the-treatment-of-children-and-adults-living-with-phenylketonuria-pku-302487940.html

    PR NEWSWIRE
    23 Jun 2025
    Share Share
    PTC Therapeutics Gets Positive CHMP Opinion for Sephience for PKU
    PTC Therapeutics Gets Positive CHMP Opinion for Sephience for PKU

    25 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ptc-therapeutics-receives-positive-chmp-opinion-for-sephience-sepiapterin-for-the-treatment-of-children-and-adults-living-with-phenylketonuria-pku-302438377.html

    PR NEWSWIRE
    25 Apr 2025
    Share Share
    PTC Therapeutics' NDA for Sepiapterin Accepted for Phenylketonuria
    PTC Therapeutics' NDA for Sepiapterin Accepted for Phenylketonuria

    01 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-fda-acceptance-for-filing-of-nda-for-sepiapterin-for-the-treatment-of-pediatric-and-adult-phenylketonuria-patients-302263975.html

    PR NEWSWIRE
    01 Oct 2024
    Share Share